Appulse Corporation is a listed company. Its directors and officers file their transactions with SEDI. Appulse Corporation has had no insider filing for more than a year; the last one goes back to 19 August 2025.
Our records for Appulse Corporation go back to 2016, with 20 purchases and 10 sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 76 declarations
Appulse Corporation is a company listed on the XTSE, specializing in the development of medical technologies. It focuses on innovative solutions for the diagnosis and treatment of diseases.